PHASE I ADJUVANT RADIATION WITH DOCETAXEL IN HIGH RISK HEAD AND NECK CANCER

BACKGROUND: This phase I study was designed to determine the maximum tolerated dose (MTD) and preliminary efficacy of docetaxel with concurrent radiotherapy, (RT), in high risk squamous cell carcinoma of the head and neck (HNSCC). PATIENTS AND METHODS: Eligible patients had resected HNSCC, histologi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Clark, Joseph I., Eisner, Robert M., Hofmeister, Craig, Norton, John, Thomas, Sachdev, Choudhury, Abdul, Petruzzelli, Guy, Lathers, Deanne, Young, M. Rita I., Lau, Ann, Emami, Bahman
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047115/
https://ncbi.nlm.nih.gov/pubmed/19415031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e31818da9c7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados